|
Index of reports
> Life Threatening Events (17)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Betamethasone (Betamethasone Topical) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Betamethasone side effects in male
Reported by a physician from Japan on 2012-08-02
Patient: male
Reactions: Salmonella Sepsis, Hepatic Function Abnormal, Castleman's Disease, Platelet Count Decreased, Rash
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Truvada
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-01-08
Truvada
Dosage: 1 df, qd
Administration route: Oral
Start date: 2010-08-16
Prezista
Dosage: 800 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-01-08
End date: 2010-01-21
Norvir
Dosage: 100 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-01-08
End date: 2010-01-21
Betamethasone
Dosage: 1 df, tid
Administration route: Oral
Indication: Rash
Start date: 2010-01-18
End date: 2010-01-26
Truvada
Dosage: 1 df, qd
Administration route: Oral
Start date: 2010-02-08
End date: 2012-06-30
Betamethasone
Dosage: 1 df, tid
Administration route: Oral
Start date: 2010-01-27
End date: 2010-01-31
Other drugs received by patient: Efavirenz; Isentress; Epivir; Zerit; Loperamide Hydrochloride
Possible Betamethasone side effects in male
Reported by a physician from Japan on 2012-06-26
Patient: male, weighing 62.1 kg (136.6 pounds)
Reactions: Interstitial Lung Disease, Drug Ineffective FOR Unapproved Indication, Upper Respiratory Tract Inflammation, Pulmonary Artery Thrombosis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Betamethasone
Dosage: unk
Administration route: Oral
Start date: 2010-07-09
Prograf
Dosage: 3 mg, uid/qd
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2010-05-13
Prograf
Dosage: 1 mg, uid/qd
Administration route: Oral
Start date: 2010-04-30
End date: 2010-05-06
Levofloxacin
Dosage: 500 mg, uid/qd
Administration route: Oral
Indication: Upper Respiratory Tract Inflammation
Start date: 2010-11-05
End date: 2010-11-11
Prednisolone
Dosage: 27.5 mg, uid/qd
Administration route: Oral
Prograf
Dosage: 2 mg, uid/qd
Administration route: Oral
Start date: 2010-05-07
End date: 2010-05-12
Prednisolone
Dosage: unk
Administration route: Oral
Indication: Interstitial Lung Disease
Prednisolone
Dosage: 30 mg, uid/qd
Administration route: Oral
Start date: 2010-04-14
End date: 2010-07-09
Betamethasone
Dosage: 3 mg, unknown/d
Administration route: Oral
Indication: Interstitial Lung Disease
Other drugs received by patient: Flaveric; Maglax; Warfarin Sodium; Codeine Phosphate; Urokinase; Nizatidine; Lasix; Heparin Calcium; Heparin Calcium; Cotrim; Mucosolvan; Gastrom; Mucodyne; Urokinase; Warfarin Sodium
Possible Betamethasone side effects in male
Reported by a physician from Japan on 2012-06-21
Patient: male, weighing 62.1 kg (136.6 pounds)
Reactions: Interstitial Lung Disease, Drug Ineffective FOR Unapproved Indication, Upper Respiratory Tract Inflammation, Pulmonary Artery Thrombosis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Prednisolone
Dosage: unk mg, uid/qd
Administration route: Oral
End date: 2010-07-09
Prograf
Dosage: 3 mg, uid/qd
Administration route: Oral
Start date: 2010-05-13
Prednisolone
Dosage: 30 mg, unknown/d
Administration route: Oral
Prednisolone
Dosage: 30 mg, uid/qd
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2010-04-14
Prograf
Dosage: 1 mg, uid/qd
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2010-04-30
End date: 2010-05-06
Prograf
Dosage: 2 mg, uid/qd
Administration route: Oral
Start date: 2010-05-07
End date: 2010-05-12
Betamethasone
Dosage: unk
Administration route: Oral
Start date: 2010-07-09
Betamethasone
Dosage: 3 mg, unknown/d
Administration route: Oral
Indication: Interstitial Lung Disease
Prednisolone
Dosage: 27.5 mg, unknown/d
Administration route: Oral
Other drugs received by patient: Nizatidine; Urokinase; Codeine Phosphate; Heparin Calcium; Flaveric; Lasix; Mucodyne; Urokinase; Warfarin Sodium; Gastrom; Levofloxacin; Heparin Calcium; Cotrim; Mucosolvan; Maglax; Warfarin Sodium
Possible Betamethasone side effects in male
Reported by a physician from Sweden on 2012-06-13
Patient: male, weighing 67.0 kg (147.4 pounds)
Reactions: Pneumonia, Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-03-07
Betamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-15
End date: 2012-01-06
Velcade
Indication: Multiple Myeloma
Start date: 2011-12-15
End date: 2012-01-05
Velcade
Start date: 2012-02-02
End date: 2012-02-23
Betamethasone
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-24
Other drugs received by patient: Laxoberal; Digoxin; Robinul; Imovane; Polyethylene Glycol; Folic Acid; Novokeptol; Bisoprolol Fumarate; Betaprol; Oxazepam
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2012-05-22
Patient: 74 year old female, weighing 44.5 kg (97.9 pounds)
Reactions: Diabetes Mellitus, Neoplasm Progression, Brain Neoplasm
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Temodal
Dosage: 100 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-05-25
End date: 2011-05-29
Temodal
Dosage: 100 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-02-21
End date: 2011-04-03
Betamethasone
Dosage: po
Administration route: Oral
Indication: Brain Neoplasm
Start date: 2011-02-15
End date: 2011-03-03
Other drugs received by patient: Trimethoprim; Cotrim; Famotidine
Possible Betamethasone side effects in male
Reported by a physician from Sweden on 2012-04-20
Patient: male, weighing 67.0 kg (147.4 pounds)
Reactions: Pneumonia, Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Betamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-15
End date: 2012-01-06
Betamethasone
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-24
Velcade
Indication: Multiple Myeloma
Start date: 2011-12-15
End date: 2012-01-05
Velcade
Start date: 2012-02-02
End date: 2012-02-23
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-03-07
Other drugs received by patient: Bisoprolol Fumarate; Folic Acid; Digoxin; Novokeptol; Oxazepam; Polyethylene Glycol; Laxoberal; Betaprol; Robinul; Imovane
Possible Betamethasone side effects in female
Reported by a physician from France on 2012-04-11
Patient: female
Reactions: Respiratory Disorder, Agranulocytosis, Cellulitis, Bacteraemia, Hyperthermia, Sepsis, Bone Marrow Failure, Septic Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 15mg per day
Administration route: Oral
Indication: Depression
Start date: 2011-01-25
End date: 2011-03-14
Chlormadinone Acetate TAB
Dosage: 10mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-03-14
Lepticur
Dosage: 10mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-15
End date: 2011-03-14
Betamethasone
Administration route: Topical
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-25
End date: 2011-03-14
Tercian
Dosage: 112.5mg per day
Administration route: Oral
Indication: Mental Disorder
Start date: 2011-01-25
End date: 2011-03-14
Estradiol
Dosage: 2mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-01
End date: 2011-03-14
Other drugs received by patient: Lyrica; Acetaminophen; Lansoyl; Cardiocalm; Ixel; Magne B6; Loceryl; Heptamyl; Tegretol; Desloratadine; Xanax; Noctamide
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2012-03-23
Patient: 74 year old female, weighing 59.1 kg (130.0 pounds)
Reactions: Anaemia, Cerebral Atrophy, Device Related Infection, Oropharyngeal Candidiasis, Hypophagia, Oliguria, Delayed Effects of Radiation, Hypoalbuminaemia, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Betamethasone
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-09
Betamethasone
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-08-08
End date: 2009-08-11
Betamethasone
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-10-24
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Cortril
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-22
Cortril
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-11-10
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-09-10
End date: 2009-09-25
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-08-25
End date: 2009-08-29
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-06-01
End date: 2009-07-12
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-11-09
End date: 2009-11-13
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-08-10
End date: 2009-08-14
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-09-14
End date: 2009-10-16
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-10-12
End date: 2009-10-16
Other drugs received by patient: Gabapentin; Zosyn; Juzen-Taiho-TO; Atarax; Isotonic Sodium Chloride Solution; Bactrim; Depakene; Primperan TAB; Gentamicin Sulfate; Hepaflush; Mobenzocin; Phenobarbital TAB; Piperacillin Sodium; Amlodipine; Ramelteon; Amoxicillin; Mystan; Diazepam; Cravit (Levofloxacin Hydrate); Tegretol; Proheparum; Predopa; Soldem 3A (Maintenance Mediium 3); Lansoprazole; Olmesartan Medoxomil; Ubretid; Lactec (Lactated Ringer's Solution); Lactulose; Aspara (L-Aspartate Potassium); Mucosil-10; Isotonic Sodium Chloride Solution; Ebrantil; Soldem (3A (Maintenance Medium 3); Sodium Chloride; Enteronon R (Antibiotics-Resistant Lactic Acid Bacteriae); Cefazolin Sodium; Decadron; Zolpidem; Vancomycin Hydrochloride; Water FOR Injections; Seloken L; Rinderon-VG; Aminoleban (Amino Acid Preparations FOR Hepatic Insufficiency 1); Solyugen G (Acetated Ringer's Solution with Glucose 1); Phenytoin Sodium CAP; Zonisamide; Stronger NEO-Minophagen C; Sefirom
Possible Betamethasone side effects in 68 year old male
Reported by a physician from Japan on 2012-03-20
Patient: 68 year old male, weighing 65.0 kg (143.0 pounds)
Reactions: Disseminated Intravascular Coagulation, Palmar-Plantar Erythrodysaesthesia Syndrome, Pyrexia, Interstitial Lung Disease, Diarrhoea, Crepitations, Anal Haemorrhage, Cough, Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Nexavar
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2010-07-05
End date: 2010-07-13
Nexavar
Dosage: 400 mg, qod
Administration route: Oral
Start date: 2010-07-26
End date: 2010-09-04
Nexavar
Administration route: Oral
Start date: 2010-07-20
Betamethasone
Dosage: daily dose .5 df
Administration route: Oral
Start date: 2010-08-02
End date: 2010-09-04
Other drugs received by patient: MS Contin; Aminovact; Lansoprazole; Magmitt; Rhythmy; Morphine; Urso 250; Voltaren
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2012-03-20
Patient: 74 year old female, weighing 44.5 kg (97.9 pounds)
Reactions: Diabetes Mellitus, Aspartate Aminotransferase Increased, Neoplasm Progression, Glucose Urine Present, Brain Neoplasm
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Temodal
Dosage: 100 mg;qd;indrp ; 10 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-05-25
End date: 2011-05-29
Temodal
Dosage: 100 mg;qd;indrp ; 10 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-02-21
End date: 2011-04-03
Betamethasone
Dosage: po
Administration route: Oral
Indication: Brain Neoplasm
Start date: 2011-02-15
End date: 2011-03-03
Other drugs received by patient: Flomox (Cefcapene Pivoxil Hydrochloride Hydrate); Famotidine; Meiactms; Bfluid (Mixed Amino Acid / Carbohydrate / Electrolyte / Vitamin Combined DRU; Norvasc; Solacet F (Acetateed Ringer;s Solution); Ramelteon; Famotidine; Losartan Potassium and Hydrochlorothiazide; Glyceol (Concentrated Glyceirn, Fructose); Sulfamethoxazole and Trimethoprim; Sodium Chloride; Serotone
Possible Betamethasone side effects in 81 year old female
Reported by a physician from Japan on 2012-01-30
Patient: 81 year old female, weighing 45.0 kg (99.0 pounds)
Reactions: Off Label Use, Drug Eruption
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Pydoxal
Dosage: 10 mg, 3x/day
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-07-12
End date: 2011-11-23
Oxycodone Hydrochloride
Dosage: unk
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-11-11
End date: 2011-11-01
Lansoprazole
Dosage: 15 mg, 1x/day
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-11-09
End date: 2011-11-23
Novamin
Dosage: 5 mg, 3x/day
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2011-11-22
End date: 2011-11-23
Laxoberon
Dosage: 0.5 ml, 1x/day
Administration route: Oral
Indication: Constipation Prophylaxis
Start date: 2011-11-22
End date: 2011-11-23
Celecoxib
Dosage: 100 mg, 2x/day
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-11-10
End date: 2011-11-23
Oxycontin
Dosage: 5 mg, 2x/day
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-11-22
End date: 2011-11-23
Betamethasone
Dosage: 1 mg, 2x/day
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-11-09
End date: 2011-11-23
Acetaminophen
Dosage: 1 g, 4x/day
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-11-09
Methycobal
Dosage: 0.5 mg, 3x/day
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-11-15
End date: 2011-11-23
Amitriptyline HCL
Dosage: 10 mg, 1x/day
Administration route: Oral
Indication: Metastases To Bone
Start date: 2011-11-15
End date: 2011-11-23
Possible Betamethasone side effects in female
Reported by a physician from Japan on 2012-01-25
Patient: female
Reactions: Hypoglycaemia, Encephalopathy, Pyrexia, Acidosis, Eczema, Fall, Carnitine Deficiency, Epilepsy, Adrenal Insufficiency, Dizziness
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Meiact MS - Cefditoren Pivoxil
Dosage: daily dose 0.99 g
Administration route: Oral
Start date: 2011-04-18
End date: 2011-05-02
Betamethasone
Dosage: daily dose 4 ml
Administration route: Oral
Indication: Infantile Asthma
Start date: 2011-04-04
End date: 2011-04-22
Meiact MS - Cefditoren Pivoxil
Dosage: daily dose 1.20 g
Administration route: Oral
Indication: Upper Respiratory Tract Inflammation
Start date: 2011-04-04
Zyrtec
Dosage: daily dose 0.4 g
Administration route: Oral
Indication: Eczema
Start date: 2011-04-27
End date: 2011-05-02
Meiact MS - Cefditoren Pivoxil
Dosage: daily dose 0.99 g
Administration route: Oral
Start date: 2011-04-01
End date: 2011-04-04
Clemastine Fumarate
Dosage: daily dose 0.30 g
Administration route: Oral
Indication: Upper Respiratory Tract Inflammation
Start date: 2011-04-01
End date: 2011-05-02
Other drugs received by patient: Procaterol HCL; Azithromycin Hydrate; Carbocisteine
Possible Betamethasone side effects in 26 year old female
Reported by a physician from United States on 2012-01-16
Patient: 26 year old female
Reactions: Dystonia, Maternal Exposure During Pregnancy, Hyperammonaemia, Coma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Haloperidol
Indication: Agitation
Betamethasone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Terbutaline
Possible Betamethasone side effects in female
Reported by a physician from Japan on 2011-12-09
Patient: female
Reactions: Hypoglycaemia, Encephalopathy, Pyrexia, Eczema, Acidosis, Carnitine Deficiency, Fall, Epilepsy, Dizziness, Adrenal Insufficiency
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Clemastine Fumarate
Dosage: daily dose 0.30 g
Administration route: Oral
Indication: Upper Respiratory Tract Inflammation
Start date: 2011-04-01
End date: 2011-05-02
Meiact MS - Cefditoren Pivoxil
Dosage: daily dose 1.20 g
Administration route: Oral
Indication: Upper Respiratory Tract Inflammation
Start date: 2011-04-04
Zyrtec
Dosage: daily dose 0.4 g
Administration route: Oral
Indication: Eczema
Start date: 2011-04-27
End date: 2011-05-02
Meiact MS - Cefditoren Pivoxil
Dosage: daily dose 0.99 g
Administration route: Oral
Start date: 2011-04-18
End date: 2011-05-02
Meiact MS - Cefditoren Pivoxil
Dosage: daily dose 0.99 g
Administration route: Oral
Start date: 2011-04-01
End date: 2011-04-04
Betamethasone
Dosage: daily dose 4 ml
Administration route: Oral
Indication: Infantile Asthma
Start date: 2011-04-04
End date: 2011-04-22
Other drugs received by patient: Procaterol HCL; Carbocisteine; Azithromycin Hydrate
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2011-11-25
Patient: 74 year old female, weighing 59.1 kg (130.0 pounds)
Reactions: Oropharyngeal Candidiasis, Anaemia, Oliguria, Hypoalbuminaemia, Cerebral Atrophy, Device Related Infection, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-11-09
End date: 2009-11-13
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-06-01
End date: 2009-07-12
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-09-14
End date: 2009-09-18
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-08-10
End date: 2009-08-14
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-10-12
End date: 2009-10-16
Cortril
Dosage: po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-22
Cortril
Dosage: po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-11-10
Betamethasone
Dosage: po; po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-08-08
End date: 2009-08-11
Betamethasone
Dosage: po; po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-09
Betamethasone
Dosage: po; po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-10-24
Betamethasone Sodium Phosphate
Dosage: iv; iv; iv
Indication: Cerebral Atrophy
Start date: 2009-08-25
End date: 2009-08-29
Betamethasone Sodium Phosphate
Dosage: iv; iv; iv
Indication: Cerebral Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Betamethasone Sodium Phosphate
Dosage: iv; iv; iv
Indication: Cerebral Atrophy
Start date: 2009-09-10
End date: 2009-09-25
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Other drugs received by patient: Mobenzocin; Ebrantil; Amoxicillin; Diazepam; Phenytoin Sodium CAP; Stronger NEO-Minophagen C; Atarax; Piperacillin Sodium; Ramelteon; Mystan; Gentamicin Sulfate; Cravit (Levofloxacin Hydrate); Zonisamide; Tegretol; Enteron R (Antibiotics-Resistant Lactic Acid Bacteriae); Sefirom; Solyugen G (Acetated Ringer's Solution with Glucose 1); Water FOR Injections; Mucosil-10; Sefmazon; Soldem 3A (Maintenance Medium 3); Amlodin OD; Olmesartan Medoxomil; Decadron; Gabapentin; Hepaflush; Zosyn; Sodium Chloride; Phenobarbital TAB; Juzen-Taiho-TO; Predopa; Isotonic Sodium Chloride Solution; Isotonic Sodium Chloride Solution; Lansoprazole; Rinderon-VG; Zolpidem; Solden (3A Maintenance Medium 3); Lactulose; Aminoleban (Amino Acid Preparations FOR Hepatic Insufficiency 1); Phoheparum; Primperan TAB; Vancomycin Hychloride; Aspara (L-Aspartate Potassium); Bactrim; Seloken L; Depakene; Ubretid; Lactec (Lactated Ringer's Solution)
Possible Betamethasone side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) on 2011-10-12
Patient: 55 year old female
Reactions: Hallucination, Auditory, Drug Ineffective, Eczema, Treatment Noncompliance, Rash Pruritic, Weight Increased, Fatigue, Skin Lesion, Sedation, Depression, Eye Pruritus, Drug Hypersensitivity, Condition Aggravated, Eosinophilia, Antipsychotic Drug Level Below Therapeutic, Hyperlipidaemia, Psychotic Disorder, Pigmentation Disorder, Suicide Attempt
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Magnesium (Magnesium)
Dosage: 7.5 mg (7.5 mg,1 in 1 d)
Indication: Product Used FOR Unknown Indication
Lorazepam
Dosage: 4 mg (4 mg,1 in 1 d) ; 3 mg (3 mg,1 in 1 d) ; 2 mg (2 mg,1 in 1 d)
Indication: Product Used FOR Unknown Indication
Aripiprazole
Dosage: 60 mg (60 mg,1 in 1 d) ; 45 mg (45 mg,1 in 1 d) ; 30 mg (30 mg,1 in 1 d) ; dose halved (2 d)
Indication: Psychotic Disorder
Pravastatin
Indication: Product Used FOR Unknown Indication
Levothyroxine Sodium
Dosage: 0.05 mg (0.05 mg,1 in 1 d)
Indication: Product Used FOR Unknown Indication
Quetiapine Fumarate
Dosage: 200 mg (200 mg,1 in 1 d)
Indication: Product Used FOR Unknown Indication
Betamethasone
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Dosage: 625 mg (625 mg,1 in 1 d) ; 900 mg (900 mg,1 in 1 d)
Indication: Product Used FOR Unknown Indication
Sertraline Hydrochloride
Dosage: 100 mg (100 mg,1 in 1 d) ; 150 mg (150 mg,1 in 1 d) ; 200 mg (200 mg,1 in 1 d)
Indication: Depression
Olanzapine
Dosage: 10 mg (10 mg,1 in 1 d)
Indication: Psychotic Disorder
Risperidone
Dosage: 1 mg (1 mg,1 in 1 d)
Indication: Psychotic Disorder
Possible Betamethasone side effects in female
Reported by a physician from Japan on 2011-10-07
Patient: female
Reactions: Dermatitis Allergic, Sepsis, Toxic Epidermal Necrolysis, Liver Disorder
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Voltaren
Indication: Pyrexia
Start date: 2009-04-29
End date: 2009-04-29
Voltaren
Start date: 2009-05-10
End date: 2009-05-10
Acetaminophen
Administration route: Oral
Indication: Pyrexia
Start date: 2009-05-02
End date: 2009-05-06
Carnaculin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-04-01
End date: 2009-05-09
Betamethasone
Indication: Product Used FOR Unknown Indication
Start date: 2009-04-01
End date: 2009-05-09
Rocephin
Indication: Product Used FOR Unknown Indication
Start date: 2009-04-29
End date: 2009-05-10
Voltaren
Start date: 2009-05-01
End date: 2009-05-01
Voltaren
Start date: 2009-05-06
End date: 2009-05-06
Metilon
Indication: Pyrexia
Start date: 2009-05-01
End date: 2009-05-01
Voltaren
Start date: 2009-05-03
End date: 2009-05-03
Other drugs received by patient: Aspirin; Micardis
|
